taxifolin and Ovarian Neoplasms

taxifolin has been researched along with Ovarian Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Qazi, S; Raza, K	1
Bast, A; Boven, E; Grimbergen, JA; Kramer, K; Kuiper, K; van Acker, SA; van den Berg, DJ; van der Vijgh, WJ	1

Other Studies

2 other study(ies) available for taxifolin and Ovarian Neoplasms

Article	Year
Phytochemicals from Ayurvedic plants as potential medicaments for ovarian cancer: an in silico analysis. Journal of molecular modeling, 2021, Mar-25, Volume: 27, Issue:4 Topics: Antigens, Neoplasm; Cell Proliferation; Female; Furans; Hematoxylin; Humans; Lignans; Medicine, Ayurvedic; Molecular Docking Simulation; Ovarian Neoplasms; Phytochemicals; Quercetin	2021
Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin. Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:10 Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Breast Neoplasms; Cardiomyopathies; Catechin; Chelation Therapy; Cystadenocarcinoma, Serous; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Electrocardiography; Female; Flavonoids; Flavonols; Free Radical Scavengers; Free Radicals; Humans; Hydroxyethylrutoside; Iron; Iron Chelating Agents; Kaempferols; Mice; Mice, Nude; Molecular Structure; Neoplasm Transplantation; Ovarian Neoplasms; Quercetin; Razoxane; Rutin; Telemetry; Tumor Cells, Cultured; Weight Loss	1997

Article

Year

Phytochemicals from Ayurvedic plants as potential medicaments for ovarian cancer: an in silico analysis.

Journal of molecular modeling, 2021, Mar-25, Volume: 27, Issue:4

Topics: Antigens, Neoplasm; Cell Proliferation; Female; Furans; Hematoxylin; Humans; Lignans; Medicine, Ayurvedic; Molecular Docking Simulation; Ovarian Neoplasms; Phytochemicals; Quercetin

2021

Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin.

Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:10

Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Breast Neoplasms; Cardiomyopathies; Catechin; Chelation Therapy; Cystadenocarcinoma, Serous; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Electrocardiography; Female; Flavonoids; Flavonols; Free Radical Scavengers; Free Radicals; Humans; Hydroxyethylrutoside; Iron; Iron Chelating Agents; Kaempferols; Mice; Mice, Nude; Molecular Structure; Neoplasm Transplantation; Ovarian Neoplasms; Quercetin; Razoxane; Rutin; Telemetry; Tumor Cells, Cultured; Weight Loss

1997